Walleye Capital LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Walleye Capital LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $3.07 Million - $4.18 Million	44,500 Added 186.97%	68,300 $4.8 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $208,404 - $258,216	-2,800 Reduced 10.53%	23,800 $1.96 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $1.8 Million - $2.13 Million	21,500 Added 421.57%	26,600 $2.32 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $350,612 - $453,146	4,600 Added 920.0%	5,100 $491,000
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $59,548 - $66,136	-700 Reduced 58.33%	500 $44,000
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $1.91 Million - $2.21 Million	-22,000 Reduced 94.83%	1,200 $104,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $1.55 Million - $2.08 Million	17,700 Added 321.82%	23,200 $2.26 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $445,115 - $597,465	5,500 New	5,500 $569,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $228,384 - $309,920	-3,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.15 Million - $1.55 Million	-17,900 Reduced 84.83%	3,200 $271,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $411,140 - $519,171	6,100 Added 40.67%	21,100 $1.42 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $233,014 - $272,310	-2,900 Reduced 16.2%	15,000 $1.29 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $1.51 Million - $1.77 Million	17,900 New	17,900 $1.59 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.